Why would sequencing VEGF and PD-1 inhibition be a better option than combination therapy

Why would sequencing VEGF and PD-1 inhibition be a better option than combination therapy

User Photo
kidneycancer

3 years
468 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Guru Sonpavde, MD, Associate Professor of Medicine
Director, Urologic Oncology, UAB Comprehensive Cancer Center answers the question Why would sequencing VEGF and PD-1 inhibition be a better option than combination therapy in Kidney Cancer.
Up Next Autoplay
>